Scruggs Rick D 4
4 · SALIX PHARMACEUTICALS LTD · Filed Mar 8, 2013
Insider Transaction Report
Form 4
Scruggs Rick D
Executive Vice President
Transactions
- Sale
Common Stock
2013-03-07$49.69/sh−2,000$99,380→ 48,566 total - Sale
Common Stock
2013-03-06$49.34/sh−5,000$246,700→ 50,566 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.32 to $49.39, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.